Outlook Therapeutics’ $159 Million Private Placement

Leila Ahmed
Tagged:

Shearman & Sterling represented GMS Ventures and Investments in the transaction.Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now